PSNL Research and Charts

PSNL - Personalis Inc (Healthcare: Diagnostics & Research)

Projected Earnings Date: 2024-08-05 (Delayed quote data 2025-05-09)

Last 5.04	Change ⇓ -0.12 (-2.33%)	Volume 784,838
	Open 5.15	High 5.31	Low 4.97

8EMA (Daily) 4.51	40EMA (Daily) 3.95	50EMA (Daily) 3.98	STO (Daily) 80.545	MACD Hist (Daily) 0.351
8EMA (Weekly) 4.072	40EMA (Weekly) 4.10	50EMA (Weekly) 3.98	STO (Weekly) 29.446	MACD Hist (Weekly) 0.018


Company Profile
Personalis Inc is a provider of advanced genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Liquid Biopsy, NeXT Dx Test, and other Pharma Research Solutions.

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.